https://doi.org/10.4081/aiua.2018.2.141
Skin flap squamous cell carcinoma developed after urethroplasty
Submitted: April 13, 2018
Accepted: April 29, 2018
Published: June 30, 2018
Accepted: April 29, 2018
Abstract Views: 1258
PDF: 520
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Material and methods: Our patient underwent to Orandi penile skin flap urethroplasty then developed a urethral epidermoid carcinoma on the flap approximately 15 years later. We treated this case with a partial penectomy surgery and perineostomy. Surgery was followed by chemotherapy with cisplatin and 5-fluorouracil. The progression of the disease led to a salvage surgery of total penectomy and asportation of testicles and scrotum.
Results: Despite the success of the surgery, the disease progressed and three months after the last surgical operation the patient died.
Conclusions: Urethral carcinoma on skin flap is a rare complication of the urethroplasty surgery but with severe consequences, so we recommend to undertake a long-term urological follow up in patients undergone such kind of surgery.
How to Cite
Abate, D., Giusti, G., Caria, N., De Vita, G., Lucci Chiarissi, M., & De Lisa, A. (2018). Skin flap squamous cell carcinoma developed after urethroplasty. Archivio Italiano Di Urologia E Andrologia, 90(2), 141–142. https://doi.org/10.4081/aiua.2018.2.141
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.